Inflammation and host response

Current Opinion in Gastroenterology

Volumn 15, Issue SUPPL. 1, 1999, Pages

  Rudnicka, Wieslawa ^a   Andersen, Leif P ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003000111     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10:720-741.
2. Labigne A, de Reuse H. Determinants of Helicobacter pylori pathogenicity. Infect Agents Dis 1996; 5:191-202.
3. Rosenstock S, Kay L, Rosenstock C, Andersen LP, Bonnevie O, Jorgensen T. Relation between Helicobacler pylori infection and gastrointestinal symptoms and syndroms. Gut 1997; 41:169-176.
4. Pantzar M, Ljungh Ã, Wadström T. Plasminogen binding and activation at the surface of Helicobacler pylori CCUG 17874. Infect Immun 1998; 66:4976-4980.
5. McAtee CP, Lim MY, Fung K, Velligan M, Fry K, Chow TP, Berg DE Characterization of a Helicobacter pylori vaccine candidate by proteome techniques. J Chromat B, Biomed Sci Appl 1998; 714:325-333.
6. McAtee CP, Fry KE, Berg DE Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by 'proteome' technologies. Helicobacter 1998, 3:163-169.
7. McAtee CP, Lim MY, Fung K, Velligan M, Fry K, Chow T, Berg DE. Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by two-dimensional gel electrophoresis, sequence analysis, and serum profiling. Clin Diag Lab Immunol 1998; 5:537-542.
8. Cao P, McClain MS, Forsyth MH, Cover TL Extracellular release of antigenic proteins by Helicobacter pylori Infect Immun 1998; 66:2984-2986.
9. Rudnicka W, Chmiela M, Czkwianianc E, Paziak-Domanska B, Rozalska B, Planeta-Malecka I. The ingestion of Helicobacter pylori by macrophages in the presence of sera from children with or without dyspeptic symptoms. Bull Pol Acad Sci 1998; 46:69-77.
10. Yokota Si, Amano Ki, Hayashi S, Kubota T, Fujii N, Yokochi T. Human antibody response to Helicobacter pylori lipopolysaccharide: presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide. Infect Immun 1998; 66:3006-3011.
11. Yamaoka Y, Kodama T, Graham DY, Kashima K. Search for putative virulence factors of Helicobacter pylori: the low-molecular-weight (33-35 K) antigen. Dig Dis Sci 1998; 43:1482-1487.
12. Kassai K, Yoshikawa T, Yoshida N, Hashiramoto A, Kondo M, Murase H. Helicobacter pylori water extract induces interleukin-8 production by gastric epithelial cells. Dig Dis Sei 1999; 44:237-242.
13. Wang JT, Chang CS, Lee CZ, Yang JC, Lin JT, Wang TH. Antibody to Helicobacter pylori species specific antigen in patients with adenocarcinoma of the stomach. Biochem Biophys Res Commun 1998; 244:360-363.
14. Osaki T, Yamaguchi H, Taguchi H, Fukuda M, Kawakami H, Hirano H. et al. Establishment and characterization of a monoclonal antibody to inhibit adhesion of Helicobacter pylori to gastric epithelial cells. J Med Microbiol 1998; 47:505-512.
15. Yamaguchi H, Osaki T, Taguchi H, Kamiya S. Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin. FEMS Microbiol Lett 1998; 168:277-282.
16. Birkholz S, Schneider T, Knipp U, Stallmach A, Zeitz M. Decreased Helicobacter pylori-specific gastric secretory IgA antibodies in infected patients. Digestion 1998; 59:638-645.
17. Futagami S, Takahashi H, Norose Y, Kobayashi M. Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites. Gut 1998, 43: 168-175. The patterns of IgG and IgA responses to H. pylori urease and presence or absence of B cells producing anti-urease antibodies allow determination of the stage of chronic gastritis.
18. Hayashi S, Sugiyama T, Yokota K, Isogai H, Isogai E, Oguma K et al. Analysis of immunoglobulin A antibodies to Helicobacter pylori in serum and gastric juice in relation to mucosal inflammation. Clin Diag Lab Immunol 1998, 5:617-621.
19. Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell Immunol 1999, 191:74-80.
20. Ierardi E, Francavilla R, Balzano T, Negrini R, Francavilla A. Autoantibodies reacting with gastric antigens in Helicobacter pylori associated body gastritis of dyspeptic children. Ital J Gastroenterol Hepatol 1998, 30:478-480.
21. Stolte M, Meier E, Meining A. Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year old male. Zeitsch Gastroenterol 1998, 36:641-643.
22. Kobayashi K, Yokota K, Yoshino T, Kawahara Y, Dey A, Hirai Y. et al. Detection of Helicobacter pylori associated antigen and heat shock protein 60 on follicular dendritic cells in the germinal centres of low grade B cell lymphoma of gastric mucosa associated lymphoid tissue (MALT). J Clin Pathol 1998, 51:396-398. Human hsp 60, which cross-reacts with anti-H pylori antibodies, is often expressed on follicular dendritic cells in gastric MALT lymphoma tissues and may be aetiologically relevant to lymphomagenesis of MALT lymphoma.
23. Nakamura S, Aoyagi K, Furuse M, Suekane H, Matsumoto T, Yao T. et al. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 1998, 152:1271-1279.
24. Barton SG, Winrow VR, Rampton DS, Crabtree JE, Beales IL, Calam J. Circulating antibodies to the 60-kD heat shock protein (hsp) family in patients with Helicobacter pylori. Clin Exp Immunol 1998, 112:490-494. In patients infected with CagA-positive H. pylori strains, IgA antibodies to hsp60 were associated with gastroduodenal disease, particularly gastric atrophy. The raised titres of such antibodies could either contribute to gastric atrophy or result from greater gastric mucosal damage induced by CagA-positive as opposed to CagA-negative strains.
25. Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998, 19:387-394.
26. Taylor DE, Rasko DA, Sherburne R, Ho C, Jewell LD. Lack of correlation between Lewis antigen expression by Helicobacter pylori and gastric epithelial cells in infected patients. Gastroenerol 1998, 115:1113-1122.
27. Heneghan MA, Moran AP, Feeley KM, Egan EL, Goulding J, Connoly CE, McCarthy CF. Effect of host Lewis and ABO blood group antigen expression on Helicobacter pylori colonisation density and the consequent inflammatory response. FEMS Immunol Med Microbiol 1998, 20:257-266.
28. Faller G, Steininger H, Appelmelk B, Kirchner T. Evidence of novel pathogenic pathways for the formation of antigastric autoantibodies in Helicobacter pylori gastritis. J Clin Pathol 1998, 51:244-245.
29. Chmiela M, Wadström T, Folkesson H, Planeta-Malecka I, Czkwianianc E, Rechcinski T, Rudnicka W. Anti-Lewis X antibody and Lewis X-anti-Lewis X immune complexes in Helicobacter pylori infection. Immunol Lett1998, 61:119-125.
30. Monteiro MA, Chan KH, Rasko DA, Taylor DE, Zheng PY, Appelmelk BJ. et al. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J Biol Chem 1998, 273:11533-11543.
31. Monteiro MA, Rasko D, Taylor DE, Perry MB. Glucosylated N-acetyllactosamine-O antigen chain in the lipopolysaccharide from Helicobacter pylori strain UA861. Glycobiol 1998, 8:107-112.
32. Mohammadi M, Redline R, Nedrud J, Czinn S. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun 1996, 64:238-245
33. Blanchard TG, Czinn SJ. Immunological determinants that may affect the HeHcobacter pylori cancer risk. Aliment Pharmacol Therap 1998, 12 Suppl 1:83-90.
34. Wang X, Willen R, Wadström T, Aleljung P. RAPD-PCR, histopathological and serological analysis of four mouse strains infected with multiple strains of Helicobacter pylori. Microbiol Ecol Health Dis 1998, 10:148-154.
35. Ferrera RL, Thiberge JM, Huerre M, Labigne A. Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun 1998, 66:1349-1355.
36. Imanishi J, Kita M, Yamaoka Y, Sawai N, Tanahashi T, Kodama T. Role of cytokines in the pathogenesis of gastrointestinal diseases associated with Helicobacter pylori infection. Compt Rend Seanc Soc Biol Filial 1998, 192:991-996.
37. Kim JS, Jung HC, Kim JM, Song IS, Kim CY. Interleukin-8 expression by human neutrophils activated by Helicobacter pylori soluble proteins. Scand J Gastroenterol 1998, 33:1249-1255.
38. Suzuki H, Suzuki M, Mori M, Kitahora T, Yokoyama H, Miura S. et al. Augmented levels of gastric mucosal leucocyte activation by infection with cagA gene-positive Helicobacter pylori. J Gastroenterol Hepatol 1998, 13:294-300
39. Akopyantas NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA. et al. Analysis of cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998, 28:37-53.
40. + H. pylori strains induce increased NF-κB-DNA binding activity, which elevates IL-8 expression by gastric epithelial cells.
41. Glocker E, Lange C, Covacci A, Bereswill S, Kist M, Pahl HL: Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-κ;B activation. Infect Immun 1998, 66:2346-2348. The activation of the transcription factor NF-κB is indispensable for H. pylori-induced IL-8 secretion and requires six membrane proteins encoded within the cag pathogenicity island.
42. Peek RM. Jr, Thompson SA, Donahue JP, Tham KT, Atherton JC, Blaser MJ, Miller GG. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Amer Physic 1998, 110:531-544. Adherence of H. pylori to gastric epithelial cells in vitro stimulates the transcription of iceA1, an H. pylori gene that is highly correlated with pathological outcome.
43. Van Doorn L-J, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, De Boer W, Quint W. Clinical relevance of the cagA , vacA, and iceA status of Helicobacter pylori. Gastroenterol 1998, 115:58-66. The relationship between H. pylori vacA s1, cagA, and iceA1 (induced by contact with epithelium) status and severity of disease is demonstrated.
44. Ogura K, Takahashi M, Maeda S, Ikenoue T, Kanai F, Yoshida H. et al. Interleukin-8 production in primary cultures of human gastric epithelial cells induced by Helicobacter pylori. Dig Dis Sci 1998 43:2738-2743.
45. Yoshida M, Wakatsuki Y, Kobayashi Y, Itoh T, Murakami K, Mizoguchi A. et al. Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori. Infect Immun 1999, 67:286-293.
46. Bliss CM. Jr, Golenbock DT, Keates S, Linevsky JK, Kelly CP. Helicobacter pylori lipopolysaccharide binds to GD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun 1998, 66:5357-5363.
47. Makristathis A, Rokita E, Labigne A, Willinger B, Rotter ML, Hirschl AM. Highly significant role of Helicobacter pylori urease in phagocytosis and production of oxygen metabolites by human granulocytes. J Infect Dis 1998, 177:803-806.
48. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, Imanishi J. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 1998, 42:609-617.
49. Shimoyama T, Everett SM, Dixon MF, Axon ATR, Crabtree JE. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol 1998, 51:765-770.
50. α, in Helicobacter pylori-associated gastric disease. J Gastroenterol Hepatol 1998, 13:516-520.
51. Ando T, Kusugami K, Ohsuga M, Ina K, Ichiyama S, Nada T, Ohta M. Mucosal macrophage inflammatory protein-1 alpha levels are increased in Helicobacter pylori infection. J Clin Gastroenterol 1998, 27 Suppl 1:3144-S149.
52. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK. et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori infection have a T helper cell phenotype. Gastroenterol 1998, 114:482-492.
53. + lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun 1998, 66:5543-5546.
54. Elios MMD, Amedei A, Del Prete G: Host response to Helicobacter pylori infection: the Th1 2 balance. Clin Microbiol Infect 1999, 5 Suppl 3:42.
55. Fan X, Crowe SE, Behar S, Gunasena H, Ye G, Haeberle H. et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1 mediated damage. J Exp Med 1998, 187:1659-1669. Class II MHC molecules were identified as a possible receptors of H. pylori. IFN-γ increases class II MHC expression on gastric epithelial cells, the attachment of the bacteria and the apoptosis of cells expressing class Il MHC molecules.
56. Molinari M, Salio M, Galli C, Norais N, Rappuoli R, Lanzavecchia A, Montecucco C. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 1998, 187:135-140. It is suggested that VacA toxin interferes with protective immunity by a partial inhibition of MHC class II-dependent antigen presentation.
57. Rudnicka W, Covacci A, Wadström T, Chmiela M. A recombinant fragment of Helicobacter pylori CagA affects proliferation of human cells. J Physiol Pharmacol 1998, 49,111-119.
58. Dubois A, Berg DE, Incecik ET, Fiala N, Heman-Ackah LM, Del Valle J. et al. Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates. Gastroenterol 1999, 116:90-96.
59. Gomez-Duarte OG, Lucas B, Yan ZX, Panthel K, Haas R: Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 1998, 16:460-471.
60. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R. et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp med 1998, 188:2277-2288. The studies indicate that protection of mice against H. pylori infection by immunization with urease antigen is dependent on MHC class II-restricted, cell-mediated mechanisms, and antibody responses to urease are not required for protection.
61. Guy B, Hessler C, Fourage S, Haensler J, Vialon-Lafay E, Rokbi B, Millet M-J Q. Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 1998, 16:850-856.
62. Saldinger PF, Porta N, Launois P, Louis JA, Waanders GA, Bouzourena H. et al. Immunization of BALB/c mice with Helicobacter pylori urease B induces a T helper 2 response absent in Helicobacter infection. Gestroenterol 1998, 115:891-897.
63. Kleanthous H, Myers GA, Georgakopoulos KM, Tibbitts TJ, Ingrassia JW, Gray HL. et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 1998, 66:2879-2886.
64. Crabtree JE: Eradication of chronic H. pylori infection by therapeutic vaccination. Gut 1998, 43:7-8.
65. Marchetti M, Rossi M, Giannelli V, Giuliani MM, Piazza M, Censini S, et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 1998, 16:33-37.
66. Pappo J, Torrey D, Castriotta L, Savinainen A, Kabok Z, Ibraghimov A. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 1999, 67:337-341.
67. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y. et al. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory respsonse in mouse model. Infect Immun 1999, 67:279-285.
68. Dubois A, Lee CK, Fiola N, Kleanthous H, Mehlmann PT, Monath T. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun 1998, 66:4340-4346. Oral administration of recombinant urease plus LT enterotoxin of E. coli significantly protected nonhuman primates against H. pylori infection while not causing undesirable side-effects.
69. Eaton KA, Ringler SS, Krakowka S. Vaccination of gnotobiotic piglets against Helicobacter pylori. J Infect Dis 1998, 178:1399-1405.